Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome

類似資料

• Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
  著者:: Gu, Chunyan, 等
  出版事項: (2018)
• Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
  著者:: Gu, Chunyan, 等
  出版事項: (2019)
• FOXM1 is a therapeutic target for high-risk multiple myeloma
  著者:: Gu, Chunyan, 等
  出版事項: (2015)
• Germline Risk Contribution to Genomic Instability in Multiple Myeloma
  著者:: Janz, Siegfried, 等
  出版事項: (2019)
• Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma
  著者:: Rosean, Timothy R., 等
  出版事項: (2014)